{"id":"https://openalex.org/W1994256100","doi":"https://doi.org/10.1210/jcem.85.4.6559","title":"The Combination of Insulin-Like Growth Factor I and Insulin-Like Growth Factor-Binding Protein-3 Reduces Insulin Requirements in Insulin-Dependent Type 1 Diabetes: Evidence for in VivoBiological Activity","display_name":"The Combination of Insulin-Like Growth Factor I and Insulin-Like Growth Factor-Binding Protein-3 Reduces Insulin Requirements in Insulin-Dependent Type 1 Diabetes: Evidence for in VivoBiological Activity","alternate_titles":[],"publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W1994256100","doi":"https://doi.org/10.1210/jcem.85.4.6559","mag":"1994256100","pmid":"https://pubmed.ncbi.nlm.nih.gov/10770191"},"language":"en","primary_location":{"id":"doi:10.1210/jcem.85.4.6559","doi":"https://doi.org/10.1210/jcem.85.4.6559","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.85.4.6559","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994256100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000288481","display_name":"David R. Clemmons","orcid":"https://orcid.org/0000-0001-9946-788X","observed_orcids":["https://orcid.org/0000-0001-9946-788X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David R. Clemmons","raw_affiliation_strings":["Department of Medicine, University of North Carolina, Chapel Hill 27599-7170, USA. endo@med.unc.edu","Department of Medicine (D.R.C.), University of North Carolina, Chapel Hill, North Carolina 27599-7170"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of North Carolina, Chapel Hill 27599-7170, USA. endo@med.unc.edu","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Department of Medicine (D.R.C.), University of North Carolina, Chapel Hill, North Carolina 27599-7170","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104132238","display_name":"Alan Charles Moses","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]},{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan C. Moses","raw_affiliation_strings":["Joslin Diabetes Center and Beth Israel Deaconess Medical Center (A.C.M.), Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Joslin Diabetes Center and Beth Israel Deaconess Medical Center (A.C.M.), Boston, Massachusetts","institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023097825","display_name":"M J McKay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malcolm J. McKay","raw_affiliation_strings":["Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068024252","display_name":"Andreas Sommer","orcid":"https://orcid.org/0000-0003-0456-1940","observed_orcids":["https://orcid.org/0000-0003-0456-1940"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Sommer","raw_affiliation_strings":["Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101802285","display_name":"David Marc Rosen","orcid":"https://orcid.org/0000-0002-2612-236X","observed_orcids":["https://orcid.org/0000-0002-2612-236X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David M. Rosen","raw_affiliation_strings":["Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celtrix Pharmaceuticals, Inc. (M.J.M., A.S., D.M.R.), San Jose, California","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"John Ruckle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Ruckle","raw_affiliation_strings":["Northwest Kinetics (J.R.), Tacoma, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwest Kinetics (J.R.), Tacoma, Washington","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5000288481"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":6.507,"has_fulltext":true,"cited_by_count":148,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97408458,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"85","issue":"4","first_page":"1518","last_page":"1524"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":0.9800000190734863},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-binding-protein-3","display_name":"insulin-like growth factor binding protein-3","score":0.8970000147819519},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9290000200271606},{"id":"https://openalex.org/keywords/insulin-requirement-reduction","display_name":"insulin requirement reduction","score":0.7089999914169312},{"id":"https://openalex.org/keywords/continuous-subcutaneous-infusion","display_name":"continuous subcutaneous infusion","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.8418794870376587},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5928201675415039},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5913155674934387},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5772691369056702},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5132884383201599},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5045088529586792},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.4869914948940277},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.475410521030426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4230264127254486},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21102768182754517},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07419073581695557},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018972","descriptor_name":"Insulin-Like Growth Factor Binding Protein 3","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018972","descriptor_name":"Insulin-Like Growth Factor Binding Protein 3","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018972","descriptor_name":"Insulin-Like Growth Factor Binding Protein 3","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019382","descriptor_name":"Human Growth Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1210/jcem.85.4.6559","doi":"https://doi.org/10.1210/jcem.85.4.6559","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jcem.85.4.6559","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"doi:10.1210/jc.85.4.1518","doi":"https://doi.org/10.1210/jc.85.4.1518","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.85.4.1518","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:10770191","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10770191","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G4137263475","display_name":"General Clinical Research Center","funder_award_id":"M01RR000046","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G743571689","display_name":null,"funder_award_id":"AG02331","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000109056","display_name":null,"funder_award_id":"AG-02331","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1969766348","https://openalex.org/W1976352306","https://openalex.org/W1978230405","https://openalex.org/W1983685754","https://openalex.org/W2000975185","https://openalex.org/W2005928583","https://openalex.org/W2013612609","https://openalex.org/W2019844099","https://openalex.org/W2025724368","https://openalex.org/W2026144395","https://openalex.org/W2026792808","https://openalex.org/W2033449137","https://openalex.org/W2038669302","https://openalex.org/W2042383730","https://openalex.org/W2047752191","https://openalex.org/W2056504539","https://openalex.org/W2063890532","https://openalex.org/W2066114232","https://openalex.org/W2078710800","https://openalex.org/W2081096579","https://openalex.org/W2089751119","https://openalex.org/W2095306595","https://openalex.org/W2103273602","https://openalex.org/W2109421896","https://openalex.org/W2117315109","https://openalex.org/W2134758256","https://openalex.org/W2137236972","https://openalex.org/W2140216489","https://openalex.org/W2153356008","https://openalex.org/W2158344034","https://openalex.org/W2158632654","https://openalex.org/W2174542542","https://openalex.org/W2426248026"],"related_works":["https://openalex.org/W2080298074","https://openalex.org/W2037135682","https://openalex.org/W1965650252","https://openalex.org/W2098307715","https://openalex.org/W1970598996","https://openalex.org/W2093424366","https://openalex.org/W2125159399","https://openalex.org/W1987454026"],"abstract_inverted_index":{"Insulin-like":[0],"growth":[1],"factor-I":[2],"(IGF-I)":[3],"enhances":[4],"insulin":[5,149,174,206,221,321,364,418,444],"action":[6],"in":[7,11,29,47,81,227,248,257,325,417,420,441],"normal":[8],"subjects":[9,353],"and":[10,17,69,85,168,181,194,212,351,436,446],"patients":[12,95,421,442],"with":[13,25,49,90,234,240,377,422,443],"both":[14],"type":[15,82,423],"1":[16,83,424],"2":[18,109],"diabetes;":[19],"however,":[20],"its":[21],"administration":[22],"is":[23,406],"associated":[24,89],"significant":[26,269],"side":[27,54,87],"effects":[28,88],"a":[30,120,126,140,170,415],"high":[31],"percentage":[32],"of":[33,37,63,131,155,172,199,349,363,384,398,438],"patients.":[34],"The":[35,129],"coadministration":[36],"IGF":[38,44],"binding":[39,45],"protein-3":[40],"(IGFBP-3,":[41],"the":[42,61,132,192,197,249,314,323,433],"predominant":[43],"protein":[46,67],"serum)":[48],"IGF-I":[50,52,64,92,99],"limits":[51],"inducible":[53],"effects,":[55],"but":[56,144,236,265,277],"it":[57],"does":[58],"not":[59,246,268],"attenuate":[60],"ability":[62],"to":[65,147,151,284,302,339,374,431],"enhance":[66],"synthesis":[68],"bone":[70],"accretion;":[71],"therefore,":[72],"we":[73],"determined":[74],"whether":[75],"IGF-I/IGFBP-3":[76,318,405],"would":[77],"retain":[78],"biological":[79],"activity":[80],"DM":[84],"limit":[86],"free":[91,378],"administration.":[93],"Twelve":[94],"received":[96,125],"recombinant":[97],"human":[98],"plus":[100],"IGFBP-3":[101],"(2":[102],"mg/kg-day)":[103],"by":[104,210,218,263,316,335,414],"continuous":[105],"sc":[106],"infusion":[107],"for":[108,178],"weeks.":[110],"Each":[111],"subject":[112,395],"served":[113],"as":[114,370,412],"his":[115],"own":[116],"control;":[117],"and,":[118],"during":[119,185,224],"paired":[121],"2-week":[122,201],"period,":[123],"each":[124,200],"placebo":[127],"infusion.":[128],"order":[130],"treatments":[133],"was":[134,183,216,254,267,275,328,368],"randomized.":[135],"Subjects":[136,158],"were":[137,145,208,333,381],"placed":[138],"on":[139,231,310,409],"constant":[141],"caloric":[142],"intake":[143],"allowed":[146],"adjust":[148],"doses":[150,207],"maintain":[152],"appropriate":[153],"levels":[154,222,261,332],"glycemic":[156],"control.":[157],"measured":[159,413],"blood":[160],"glucose":[161,215,243],"four":[162,186],"times":[163],"per":[164],"day":[165],"at":[166,191,196,358],"home":[167,359],"kept":[169],"log":[171],"their":[173],"use.":[175],"Frequent":[176],"sampling":[177,226],"glucose,":[179],"insulin,":[180],"GH":[182,327,331],"conducted":[184],"inpatient":[187],"study":[188,202],"periods,":[189],"one":[190,195],"beginning":[193],"end":[198],"interval.":[203],"During":[204],"IGF-I/IGFBP-3,":[205,232],"reduced":[209,217,334],"49%,":[211],"mean":[213],"serum":[214,326],"23%.":[219],"Free":[220],"obtained":[223],"frequent":[225],"hospital":[228],"fell":[229],"47%":[230],"compared":[233],"control,":[235],"showed":[237],"no":[238,255,382],"change":[239,256,324],"placebo.":[241],"Concomitant":[242],"measurements":[244],"did":[245],"differ":[247],"two":[250],"treatment":[251],"groups.":[252],"There":[253],"body":[258],"weight.":[259],"Fructosamine":[260],"decreased":[262],"12%,":[264],"this":[266,439],"(P":[270,289,307,342],"<":[271,290,308,343],"0.1).":[272],"Fasting":[273],"triglyceride":[274],"unchanged,":[276],"cholesterol":[278],"declined":[279],"from":[280,298,337],"170":[281],"+/-":[282,286,300,304],"24":[283],"149":[285],"31":[287],"mg/dL":[288],"0.05).":[291],"IGFBP-2":[292],"(an":[293],"IGF-I-dependent":[294],"responsive":[295],"variable)":[296],"rose":[297],"141":[299],"56":[301],"251":[303],"98":[305],"ng/mL":[306,341],"0.01)":[309],"IGF-I/IGFBP-3.":[311],"To":[312],"analyze":[313],"mechanism":[315],"which":[317],"might":[319],"reduce":[320],"requirements,":[322],"quantified.":[329],"Mean":[330],"72%,":[336],"2.48":[338],"0.55":[340],"0.001).":[344],"An":[345],"equal":[346],"number":[347],"(40%)":[348],"drug-":[350],"placebo-treated":[352],"had":[354],"minor":[355],"hypoglycemic":[356],"episodes":[357],"that":[360,404],"required":[361,430],"adjustment":[362],"doses.":[365],"No":[366,394],"episode":[367],"classified":[369],"severe.":[371],"In":[372],"contrast":[373],"previous":[375],"studies":[376,427],"IGF-I,":[379],"there":[380],"cases":[383],"edema,":[385,390],"headache,":[386],"jaw":[387],"pain,":[388],"retinal":[389],"or":[391],"Bell's":[392],"palsy.":[393],"withdrew":[396],"because":[397],"drug":[399],"complications.":[400],"These":[401],"findings":[402],"indicate":[403],"biologically":[407],"active":[408],"carbohydrate":[410],"metabolism,":[411],"decrease":[416],"requirements":[419],"diabetes.":[425,447],"Further":[426],"will":[428],"be":[429],"determine":[432],"long-term":[434],"safety":[435],"efficacy":[437],"combination":[440],"resistance":[445]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994256100","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
